Nitric oxide synthase in models of focal ischemia - PubMed
Review
Nitric oxide synthase in models of focal ischemia
A F Samdani et al. Stroke. 1997 Jun.
Abstract
Background and purpose: Cessation of blood flow to the brain, for even a few minutes, sets in motion a potential reversible cascade of events resulting in neuronal cell death. Oxygen free radicals and oxidants appear to play an important role in central nervous system injury after cerebral ischemia and reperfusion. Recently, divergent roles for the newly identified neuronal messenger molecule and oxygen radical, nitric oxide (NO), have been identified in various models of cerebral ischemia. Because of the chemical and physical properties of NO, the numerous physiological activities it mediates, and the lack of specific agents to modulate the activity of the different isoforms of NO synthase (NOS), reports regarding the role of NO in focal cerebral ischemia have been confounding and often conflicting. Recent advances in pharmacology and the development of transgenic knockout mice specific for the different isoforms of NOS have advanced our knowledge and clarified the role of NO in cerebral ischemia.
Methods: Animal models of focal ischemia employ occlusion of nutrient cerebral vessels, most commonly the middle cerebral artery. Primary cortical cultures are exposed to excitotoxic or ischemic conditions, and the activities of NOS isoforms or NO production are evaluated. Transgenic mice lacking expression of either the neuronal isoform of NOS (nNOS), the endothelial isoform of NOS (eNOS), or the immunologic isoform of NOS (iNOS) have been examined in models of excitotoxic injury and ischemia.
Results: Excitotoxic or ischemic conditions excessively activate nNOS, resulting in concentrations of NO that are toxic to surrounding neurons. Conversely, NO generated from eNOS is critical in maintaining cerebral blood flow and reducing infarct volume. iNOS, which is not normally present in healthy tissue, is induced shortly after ischemia and contributes to secondary late-phase damage.
Conclusions: Pharmacological and genetic approaches have significantly advanced our knowledge regarding the role of NO and the different NOS isoforms in focal cerebral ischemia. nNOS and iNOS play key roles in neurodegeneration, while eNOS plays a prominent role in maintaining cerebral blood flow and preventing neuronal injury.
Similar articles
-
Wei G, Dawson VL, Zweier JL. Wei G, et al. Biochim Biophys Acta. 1999 Sep 20;1455(1):23-34. doi: 10.1016/s0925-4439(99)00051-4. Biochim Biophys Acta. 1999. PMID: 10524226
-
De Alba J, Cárdenas A, Moro MA, Leza JC, Lorenzo P, Boscá L, Lizasoain I. De Alba J, et al. J Neurochem. 1999 Jan;72(1):248-54. doi: 10.1046/j.1471-4159.1999.0720248.x. J Neurochem. 1999. PMID: 9886076
-
Genetic analysis of NOS isoforms using nNOS and eNOS knockout animals.
Huang PL, Lo EH. Huang PL, et al. Prog Brain Res. 1998;118:13-25. doi: 10.1016/s0079-6123(08)63197-0. Prog Brain Res. 1998. PMID: 9932431 Review.
-
Roles of nitric oxide in brain hypoxia-ischemia.
Bolaños JP, Almeida A. Bolaños JP, et al. Biochim Biophys Acta. 1999 May 5;1411(2-3):415-36. doi: 10.1016/s0005-2728(99)00030-4. Biochim Biophys Acta. 1999. PMID: 10320673 Review.
Cited by
-
Gonzalez-Vazquez A, Aguilar-Peralta AK, Tomas-Sanchez C, Blanco-Alvarez VM, Martinez-Fong D, Gonzalez-Barrios JA, Treviño S, Millán-Perez Peña L, Alatriste V, Soto-Rodriguez G, Brambila E, Leon-Chavez BA. Gonzalez-Vazquez A, et al. Oxid Med Cell Longev. 2021 May 6;2021:6696538. doi: 10.1155/2021/6696538. eCollection 2021. Oxid Med Cell Longev. 2021. PMID: 34040692 Free PMC article.
-
Asymmetric dimethyarginine as marker and mediator in ischemic stroke.
Chen S, Li N, Deb-Chatterji M, Dong Q, Kielstein JT, Weissenborn K, Worthmann H. Chen S, et al. Int J Mol Sci. 2012 Nov 28;13(12):15983-6004. doi: 10.3390/ijms131215983. Int J Mol Sci. 2012. PMID: 23443106 Free PMC article. Review.
-
Aliev G, Palacios HH, Gasimov E, Obrenovich ME, Morales L, Leszek J, Bragin V, Solís Herrera A, Gokhman D. Aliev G, et al. Pharmaceuticals (Basel). 2010 Jan 19;3(1):158-187. doi: 10.3390/ph3010158. Pharmaceuticals (Basel). 2010. PMID: 27713247 Free PMC article. Review.
-
Brain tissue responses to ischemia.
Lee JM, Grabb MC, Zipfel GJ, Choi DW. Lee JM, et al. J Clin Invest. 2000 Sep;106(6):723-31. doi: 10.1172/JCI11003. J Clin Invest. 2000. PMID: 10995780 Free PMC article. No abstract available.
-
Do statins afford neuroprotection in patients with cerebral ischaemia and stroke?
Vaughan CJ, Delanty N, Basson CT. Vaughan CJ, et al. CNS Drugs. 2001;15(8):589-96. doi: 10.2165/00023210-200115080-00002. CNS Drugs. 2001. PMID: 11524031
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources